Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer
Public ClinicalTrials.gov record NCT03937154. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
PROCLAIM: A Phase 3 Randomized Placebo-controlled Double-blind Study of Romiplostim for the Treatment of Chemotherapy-induced Thrombocytopenia in Patients Receiving Chemotherapy for Treatment of Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer
Study identification
- NCT ID
- NCT03937154
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Amgen
- Industry
- Enrollment
- 145 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Romiplostim Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 100 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 25, 2020
- Primary completion
- Mar 9, 2026
- Completion
- Feb 22, 2027
- Last update posted
- Apr 6, 2026
2020 – 2027
United States locations
- U.S. sites
- 27
- U.S. states
- 19
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Saint Bernards Medical Center | Jonesboro | Arkansas | 72401 | — |
| Los Angeles Cancer Network | Anaheim | California | 92801 | — |
| University of California Irvine | Orange | California | 92868 | — |
| Colorado West Healthcare System dba Grand Valley Oncology | Grand Junction | Colorado | 81505 | — |
| University of Miami School of Medicine | Miami | Florida | 33136 | — |
| Ocala Oncology Center | Ocala | Florida | 34474 | — |
| Mid Florida Hematology and Oncology Centers PA | Orange City | Florida | 32763 | — |
| Saint Alphonsus Regional Medical Center | Boise | Idaho | 83706 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| Orchard Healthcare Research Inc | Skokie | Illinois | 60076 | — |
| Christus Saint Frances Cabrini Hospital | Alexandria | Louisiana | 71301 | — |
| University Medical Center New Orleans | New Orleans | Louisiana | 70112 | — |
| Christus Highland Cancer Treatment Center | Shreveport | Louisiana | 71105 | — |
| Mercy Medical Center | Baltimore | Maryland | 21202 | — |
| American Oncology Partners, PA | Bethesda | Maryland | 20817 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Hattiesburg Clinic Hematology/Oncology | Hattiesburg | Mississippi | 39401 | — |
| Oncology Hematology Associates | Springfield | Missouri | 65807 | — |
| Great Falls Clinic | Great Falls | Montana | 59405 | — |
| Nebraska Cancer Specialists | Omaha | Nebraska | 68130 | — |
| Regional Cancer Care Associates | Sparta | New Jersey | 78071 | — |
| Broome Oncology LLC | Binghamton | New York | 13905 | — |
| Saint Lukes University Health Network | Bethlehem | Pennsylvania | 18015 | — |
| The Center for Cancer and Blood Disorders | Fort Worth | Texas | 76104 | — |
| Community Cancer Trials of Utah | Ogden | Utah | 84405 | — |
| Medical Oncology Associates PS | Spokane | Washington | 99208 | — |
| Yakima Valley Memorial Hospital | Yakima | Washington | 98902 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 112 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03937154, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 6, 2026 · Synced May 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03937154 live on ClinicalTrials.gov.